Results 121 to 130 of about 483,075 (169)
Some of the next articles are maybe not open access.
Neuroprotection in Cerebrovascular Disease
Expert Opinion on Investigational Drugs, 2000The role of neuroprotection in the management of acute cerebrovascular disease is reviewed. Neuroprotection is a valuable adjunct to thrombolytic therapy in acute cerebral ischaemia. Various pharmacological approaches for neuroprotection are based on the current knowledge of molecular events in the pathophysiology of cerebral ischaemia.
openaire +2 more sources
Pentoxifylline and Cerebrovascular Diseases
European Neurology, 2008Pentoxifylline is a drug known to increase red cell deformability, thus allowing the 7- to 8-µm diameter red cell to flow through the narrowest capillaries of 3–5 µmdiameter. Red cell deformability is reduced in various forms of cerebrovascular impairment.
G A, Marcel, C, George
openaire +2 more sources
Cerebrovascular disease and dementia
Drugs of Today, 2005Cerebrovascular disease and dementia are extremely prevalent and disabling disorders affecting older people. Results of previous pathological investigations and later epidemiological studies have raised the possibility that the two disorders may be causally related.
Velandai, Srikanth +3 more
openaire +3 more sources
microRNAs in Cerebrovascular Disease
2015Cardiovascular diseases are major causes of morbidity and mortality in developed countries. Cerebrovascular diseases, especially stroke, represent major burden of disability and economy impact. Major advances in primary and secondary prevention and therapy are needed in order to tackle this public health problem.
Ondřej, Volný +4 more
openaire +2 more sources
Headache and cerebrovascular diseases
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2021Headache is a common symptom of acute and chronic cerebrovascular diseases. Headache can be symptomatic in patients with various forms of vascular pathology of the brain but primary headaches are much more common. Secondary headaches in acute cerebrovascular accidents may be the first symptom, and in some cases, a risk factor or complication of stroke.
openaire +2 more sources
Hypertension and Cerebrovascular Disease
Primary Care: Clinics in Office Practice, 1980Although hypertension is the greatest risk factor for stroke, its control with antihypertensive drugs improves survival and decreases the incidence of stroke. If a stroke should occur, careful antihypertensive therapy has not been harmful. Sodium nitroprusside is the initial drug of choice in acute crises.
D J, Breslin, N W, Swinton
openaire +2 more sources
Headache in cerebrovascular diseases
S.S. Korsakov Journal of Neurology and PsychiatryHeadache is a common symptom of cerebrovascular diseases. This paper presents a literature review with a search depth of 20 years on the clinical features of headache as a criterion for diagnosing or raising clinical suspicion of acute or chronic cerebrovascular disease.
R.G. Esin +3 more
openaire +2 more sources
Cancer and Cerebrovascular Disease
Current Neurology and Neuroscience Reports, 2019To review the latest information about the interactions between cancer and cerebrovascular disease.Additional data support the finding that both ischemic and hemorrhagic stroke are important complications of cancer or its treatment. Reperfusion therapy is being given successfully to patients with stroke complicating cancer. Hemorrhagic stroke may occur
openaire +2 more sources
Cerebrovascular diseases and depression
Current Psychiatry Reports, 2003Cerebrovascular diseases constitute a leading health hazard. The association between stroke and depression has been recognized for many years. Depression is the most common psychiatric disorder associated with cerebrovascular diseases, most episodes of post-stroke depression occur in the first 2 years after a cerebrovascular accident.
Himani, Ghoge +3 more
openaire +2 more sources
Microalbuminuria in cerebrovascular diseases
Expert Review of Neurotherapeutics, 2003Microalbuminuria was originally introduced to clinical practice as a useful marker of incipient diabetic nephropathy. The growing body of evidence suggests that increased urinary albumin excretion is related to the increased risk of cardiovascular events and all causes mortality in subjects with or without diabetes.
Wojciech, Turaj +2 more
openaire +2 more sources